Bourgeon Capital Management LLC Merck & Co., Inc. Transaction History

Bourgeon Capital Management LLC

$520 Million
Q3 2024

A detailed history of Bourgeon Capital Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bourgeon Capital Management LLC holds 146,806 shares of MRK stock, worth $14.4 Million. This represents 3.21% of its overall portfolio holdings.

Number of Shares

146,806

Previous 143,490 2.31%

Holding current value

$14.4 Million

Previous $17.8 Million 6.15%

% of portfolio

3.21%

Previous 3.5%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$111.15 - $128.97 $368,573 - $427,664	3,316 Added 2.31%	146,806 $16.7 Million
Q2 2024 Jul 11, 2024	SELL	$123.8 - $132.96 $8,170 - $8,775	-66 Reduced 0.05%	143,490 $17.8 Million
Q1 2024 Apr 19, 2024	BUY	$113.24 - $131.95 $128,753 - $150,027	1,137 Added 0.8%	143,556 $18.9 Million
Q4 2023 Jan 30, 2024	SELL	$100.18 - $109.02 $59,306 - $64,539	-592 Reduced 0.41%	142,419 $15.5 Million
Q3 2023 Nov 01, 2023	BUY	$102.95 - $114.33 $9,368 - $10,404	91 Added 0.06%	143,011 $14.7 Million
Q2 2023 Jul 20, 2023	SELL	$108.61 - $118.38 $26,609 - $29,003	-245 Reduced 0.17%	142,920 $16.5 Million
Q1 2023 Apr 17, 2023	BUY	$102.94 - $114.86 $4,529 - $5,053	44 Added 0.03%	143,165 $15.2 Million
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $2.26 Million - $2.9 Million	-25,893 Reduced 15.32%	143,121 $0
Q3 2022 Oct 27, 2022	BUY	$84.53 - $94.96 $96,364 - $108,254	1,140 Added 0.68%	169,014 $14.6 Million
Q2 2022 Jul 27, 2022	BUY	$83.49 - $94.64 $97,683 - $110,728	1,170 Added 0.7%	167,874 $15.3 Million
Q1 2022 May 03, 2022	SELL	$73.51 - $82.4 $37,196 - $41,694	-506 Reduced 0.3%	166,704 $13.7 Million
Q4 2021 Jan 31, 2022	SELL	$72.28 - $90.54 $68,087 - $85,288	-942 Reduced 0.56%	167,210 $12.8 Million
Q3 2021 Nov 09, 2021	BUY	$71.68 - $78.83 $219,699 - $241,613	3,065 Added 1.86%	168,152 $12.6 Million
Q2 2021 Jul 19, 2021	BUY	$70.31 - $77.77 $831,767 - $920,019	11,830 Added 7.72%	165,087 $12.8 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $622,494 - $733,234	9,040 Added 6.27%	153,257 $11.8 Million
Q4 2020 Jan 29, 2021	BUY	$71.77 - $79.65 $2.42 Million - $2.69 Million	33,729 Added 30.53%	144,217 $11.8 Million
Q3 2020 Oct 28, 2020	BUY	$73.18 - $82.95 $56,348 - $63,871	770 Added 0.7%	110,488 $9.17 Million
Q2 2020 Jul 27, 2020	BUY	$70.42 - $80.13 $1.59 Million - $1.8 Million	22,520 Added 25.83%	109,718 $8.48 Million
Q1 2020 May 07, 2020	BUY	$63.36 - $87.82 $833,627 - $1.16 Million	13,157 Added 17.77%	87,198 $6.71 Million
Q4 2019 Feb 04, 2020	SELL	$77.58 - $87.54 $2.06 Million - $2.32 Million	-26,525 Reduced 26.38%	74,041 $6.73 Million
Q3 2019 Nov 04, 2019	SELL	$76.08 - $82.93 $7.09 Million - $7.73 Million	-93,201 Closed	0 $0
Q2 2019 Jul 18, 2019	SELL	$69.84 - $81.59 $30,380 - $35,491	-435 Reduced 0.46%	93,201 $7.82 Million
Q1 2019 Apr 29, 2019	SELL	$69.58 - $79.36 $141,664 - $161,576	-2,036 Reduced 2.13%	93,636 $7.79 Million
Q4 2018 Jan 17, 2019	SELL	$65.24 - $75.71 $688,151 - $798,589	-10,548 Reduced 9.93%	95,672 $7.31 Million
Q3 2018 Oct 25, 2018	SELL	$57.69 - $67.84 $1.13 Million - $1.32 Million	-19,520 Reduced 15.52%	106,220 $7.54 Million
Q2 2018 Jul 19, 2018	SELL	$50.83 - $59.72 $68,620 - $80,622	-1,350 Reduced 1.06%	125,740 $7.63 Million
Q1 2018 Apr 27, 2018	BUY	$50.96 - $59.23 $118,482 - $137,709	2,325 Added 1.86%	127,090 $6.92 Million
Q4 2017 Feb 05, 2018	BUY	$51.62 - $61.64 $1.68 Million - $2 Million	32,475 Added 35.19%	124,765 $7.02 Million
Q3 2017 Oct 27, 2017	BUY	$58.67 - $63.13 $5.41 Million - $5.83 Million	92,290	92,290 $5.91 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bourgeon Capital Management LLC with notifications on news.

Account

Bourgeon Capital Management LLC Merck & Co., Inc. Transaction History